Tesla will set up manufacturing in India after it selling electric vehicles there next year, according to India's transport minister, Nitin Gadkari.
CEO Elon Musk said that Tesla would "definitely" enter the Indian market, though not in January 2021.
Electric vehicle manufacturers see a lot of sales potential in India, as its n government has set an ambitious goal to reduce the number of gas-powered vehicles on its roads. It also offers subsidies and other incentives to increase the number of EVs on the market.
Mahindra was the first to sell EVs in India.
Last year, Hyundai became the second company to sell electric cars in India with its Kona Electric. The South Korean company praised India for its support for clean and connected mobility.
Since then, Tata and MG Motor have debuted their vehicles in the country, as has Daimler's Mercedes-Benz.
Musk has been planning to sell EVs in India since the summer of 2017. The delay was beneficial as car sales in India dropped sharply in 2019 as new safety and emission regulations drove up prices, and troubles among India's consumer finance providers hit lending.
Other American companies have been retreating from India over the last few years, including General Motors and motorcycle maker Harley Davidson.


Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns 



